September 8, 2011 – Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a large nationwide clinical trial has shown. The investigators published the results in the online first edition of the New England Journal of Medicine. The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, funded the trial. The medical regimen included daily blood-thinning medications and aggressive control of blood pressure and cholesterol.

September 6, 2011 — Philips has announced the availability of Xcelera R3.2, the latest release of its multi-modality cardiology image management, analysis and reporting system. It delivers patient information across the care continuum via enhanced connectivity with other hospital information systems and the patient’s electronic medical record.

September 6, 2011 — The European Society of Cardiology (ESC) released the latest version of its guidelines for managing patients presenting without persistent ST-segment elevation. This version replaces earlier editions of 2000, 2002 and 2007. The new guidelines also incorporate the findings of very recent studies.

September 6, 2011 — Stryker Corp. has signed a definitive agreement to acquire Concentric Medical for $135 million in an all-cash transaction. The acquisition provides Stryker with immediate entry into the fastest growing segment of the interventional neurovascular space.

September 6, 2011 — Mesoblast Ltd. announced it received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 European clinical trial for Revascor, its lead cardiovascular product. The study is being conducted in conjunction with angioplasty and stent procedures to gauge ability to prevent heart failure after a major heart attack.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now